bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version x rivervest fund ii lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active x rivervest fund ii lp • st louis mo • venture capital fund how do i update this listing x rivervest fund ii is based out of st louis the firm last filed a form d notice of exempt offering of securities on  the filing was for a pooled investment fund venture capital fund the notice included securities offered of pooled investment fund interests summary dg insider form  form d  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from x rivervest fund ii lp enter your email address below and choose submit your email cancel contact info x rivervest fund ii lp  south hanley road st louis mo     business phone  recent sec filings da filed on  d filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading form d filings form d is a form to be used to file a notice of an exempt offering of securities with the securities and exchange commission form d contains basic information about the offering and the company form d filings filing date form type industry group securities offered total offering amount total amount sold total remaining  da pooled investment fund venture capital fund pooled investment fund interests     d pooled investment fund venture capital fund pooled investment fund interests    other issuers in filings name address no other issuers related parties included in filings name address relationship anthony arnerich subscription required executive officer jay w schmelter subscription required executive officer john p mckearn subscription required executive officer na x partners managers ii lp subscription required executive officer na x partners managers ii llc subscription required executive officer na x rivervest partners ii llc subscription required director na rivervest x managers ii lp subscription required executive officer na rivervest x managers ii llc subscription required executive officer niall odonnell subscription required executive officer nicholas walrod subscription required executive officer thomas c melzer subscription required executive officer elevate your investments try it for free bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version rivervest venture partners coleads  million series a financing for st louisfounded startup tioma  rivervest venture partners investing in life science innovation   rivervest venture partners coleads  million series a financing for st louisfounded startup tioma st louis mo sept   – tioma therapeutics inc a rivervest portfolio company developing therapies to treat solid and bloodbased cancers announced it has raised  million in series a venture financing the series a financing included early investor rivervest along with novo ventures glaxosmithkline’s corporate venture arm sr one limited and new investors roche venture fund and x rivervest fund ii lp previously known as vasculox tioma was founded by dr william frazier a professor at the washington university school of medicine in st louis its initial seed capital of  million came primarily from rivervest st louisbased biogenerator and the missouri technology corporation a publicprivate partnership to promote entrepreneurship and foster the growth of new hightech companies “this is a fantastic example of what st louisbased innovation talent and resources can do to build biopharma companies that will make a difference” said john mckearn a rivervest managing director and tioma board chairman “st louis is a hotbed of innovative science” said tioma ceo john donovan “with great research institutions like washington university and st louis university not only is there a tremendous human talent pool in st louis but a very hospitable business environment for companies like tioma” donovan said the company plans to use the  million series a to fund human clinical trials for its lead anticancer therapy a checkpoint inhibitor that targets a protein called cd as well as to continue investing in its broad portfolio of functionally diverse antibodies to explore their potential as therapeutic agents in a wide variety of disease settings tioma is building its corporate headquarters in the bay area but the research laboratories will remain in st louis located in the cortex innovation community about tioma therapeutics inc the company was founded as vasculox inc by scientific founders including william a frazier phd professor of biochemistry molecular biophysics cell biology and biomedical engineering at washington university school of medicine dr frazier was instrumental in the discovery that cd is a receptor for thrombospondin and he has been a leader in the field of cdmediated signaling pathways for many years tioma maintains its research laboratories in st louis and a corporate office in the san francisco bay area the company has generated a portfolio of anticd antibodies that have the potential to surmount multiple checkpoints by which cancer evades the immune system these antibodies are protected by a strong multilayered intellectual property estate that includes compositionofmatter and uses of humanized anticd antibodies for more information please visit wwwtiomatherapeuticscom about rivervest venture partners rivervest venture partners is a venture capital firm focused on identifying and shaping earlystage life science companies to create significant shareholder value because of its extensive operating expertise rivervest is able to help entrepreneurs achieve nearterm objectives that position their companies for exit established in  rivervest has funded  and exited or taken public  innovative life science companies the venture capital firm has assets under management of  million   additional info tioma therapeutics inc formerly vasculox is a biopharma company developing anticd antibodies for the treatment of solid tumors and hematologic cancers including leukemia and lymphoma rivervest provided seed funding to the company prior to leading its  million series a financing rivervest managing director john mckearn chairs the company’s board of directors and bradley keller entrepreneurinresidence at rivervest is tioma’s vp of product development rivervest venture partners st louis office  s hanley road suite  st louis mo  phone  fax  inforivervestcom san diego office  high bluff drive suite  san diego ca 9 fax  inforivervestcom cleveland office  cedar avenue suite  cleveland oh  phone 9 fax  inforivervestcom newsletter sign up rivervest venture partners  investing in life science innovation investing in life science innovation   growing companies rivervest identifies and shapes companies creating significant shareholder value about us proven experience more than  years experience in research clinical operational and investment success give the rivervest team an edge in producing toptier results meet the team case studies rivervest has successfully funded  life sciences companies and facilitated  public offerings or exits view case studies rivervest venture partners® is a venture capital firm focused on identifying and shaping earlystage life science companies to create significant shareholder value because of its extensive operating expertise rivervest is able to help entrepreneurs achieve nearterm objectives that position their companies for exit portfolio companies portfolio company news genoa pharmaceuticals secures  million series a financing adds to leadership teammay  tryton medical receives fda approval for tryton side branch stent to treat signficiant coronary bifurcation lesionsmarch  amplyx pharmaceuticals announces executive appointmentsjanuary  fda grants orphan drug designation to amplyx pharmaceuticals for apx for treatment of multiple invasive fungal and mold infectionsnovember  tryton medical enters into strategic agreement with cardinal healthoctober   more news recent tweets rt biocominla thank you novoventures and rivervest for coming to biocomca la venture day invest vc lifesciences biotech https… time ago  days via twitter for iphone reply  retweet  favorite rt jlandress exciting day for biocomca cap dev  partnerday in sd with vertexpharma and a ventureday biocominla with novoventures a… time ago  days via twitter for iphone reply  retweet  favorite and leading archer is the talented karen mullis tcoolbwydd time ago 9 days via twitter for iphone reply  retweet  favorite follow rivervest on twitter rivervest news st louis venture fund makes  million bet on its hometowndecember  rivervest venture partners closes on  million biopharma preseed fundnovember  rivervest venture partners coleads  million series a financing for st louisfounded startup tiomaseptember  rivervest opens san diego office that’s been  years in the makingapril  nancy a hong joins rivervest venture partners as life sciences vc opens office in san diegoapril   more rivervest news newsletter sign up   x rivervest fund ii lp raised funds on november th  want to see morewant to find out who got funded and who’s funding the next big thing in real time all across the world tailored to your specific areas of focus deals per dayget access to the most exhaustive worldwide funding watch on the webcomprehensive funding informationknow about who invested in a company which sites covered the event the funding history etcexclusive insightsview original analytics such as most dynamic industries most active investors and morestay awareget emailed when deals critical to your business happen filter by region industry and topics of interestas seen onhave a loginsign inregister nowits freeuse your social accountor fill in the quick formregister nowpromise we wont spamsign invia your social accountvia your existing wgf accountremember meregister its freeforgot your passwordsign inforgot your passwordenter your email and we will send you your new passwordreset passwordthe worlds largest funding basedealsxrivervestfundiilpsectiondealssubsectiondetailid   search deals by company name industry location investors search x rivervest fund ii lp raised funds on november th get alertedif x rivervest fund ii lp gets fundedamountundisclosedcompanyx rivervest fund ii lpinvestorsindustryfinancecountrystatecityunited statesmissourist louiskey peopleanthony arnerich executive officer john mckearn executive officer thomas melzer executive officer niall odonnell executive officer jay schmelter executive officer nicholas walrod executive officerdata sourceswwwsecgov  d  x rivervest fund ii lp 9 filerdescriptionthe transaction was completed in november th  x rivervest fund ii lp is a financespecialized companyplease note that all data is automatically extracted and errors can occurthe whogotfunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and completeinaccurate data help us improve whogotfunded post a comment adarza biosystems bags  million series c employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       adarza biosystems bags  million series c tweet 9  am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs adarza biosystems closes on  million series c financing rochester ny and st louis mo jan 9  – adarza biosystems inc a leading next generation innovator in labelfree multiplex assays announced today that it has closed a m series c financing proceeds from the financing will be used to further expand production capacity in its st peters mo manufacturing facility and fund final development and commercialization of adarza’s first immunoassay product consumable and instrument platform adarza develops and manufactures immunoassay technology that can identify proteins and genetic markers in medical samples such as blood the technology which comes in the form of microchips helps with cancer diagnostics and allergy testing drug and vaccine development immunology and infectious diseases research and other applications x rivervest fund ii lp leads the round and rivervest managing directors dr john mckearn and jay schmelter will join the board “adarza’s air™ technology can deliver a powerful tool to researchers and clinicians” said mckearn “we are proud to support the adarza team on the path to commercialization” joining adarza biosystems as president is bryan witherbee replacing retiring ceo dr rand henke witherbee brings over  years of experience and a successful track record of developing and commercializing new technologies he most recently served as scientific leader within the genomics division at becton dickinson bd prior to that he was cso at gencell biosystems which was acquired by bd in  previously witherbee held various research and development leadership roles at monsanto and pfizer “i am very excited about joining adarza at this stage of the company’s development” said witherbee “i am looking forward to moving adarza’s innovative arrayed imaging reflectometry technology through to commercialization and introducing truly transformative labelfree multiplex products” “the investment commitment by x rivervest fund ii and having bryan witherbee join adarza as president offers adarza significant financial resources leadership and industry experience” said henke “this represents an exciting phase in adarza’s development that will take the company through final stages of commercialization and product release” about adarza biosystems inc adarza with operations in rochester ny and st louis mo is a leading developer and manufacturer of labelfree biosensor assays and instruments servicing life science research drug development and in vitro diagnostics customers adarza’s products and services utilize its proprietary arrayed imaging reflectometry “air™” detection platform that is capable of rapidly identifying and quantifying a series of biological target analyte species in a fluid sample without chemical labels or complex processing the air™ technology offers key performance benefits in sensitivity speed multiplex arrays sample size dynamic range ease of use and industry leading low cost of use adarza products address broad quantitative analyte detection applications including cancer biomarkers drug and vaccine development allergy immunology and infectious diseases research for more information visit wwwadarzabiocom about x rivervest fund ii lp x rivervest fund ii lp is a venture capital fund that invests in laterstage life science companies as well as companies that are focused on sustainability in the energy water and agricultural sectors the fund is comanaged by a joint venture between portlandbased x partners and an affiliate of st louisbased rivervest venture partners about rivervest venture partners rivervest venture partners is a venture capital firm focused on identifying and shaping earlystage life science companies to create significant shareholder value because of its extensive operating expertise rivervest is able to help entrepreneurs achieve nearterm objectives that position their companies for exit established in  rivervest has funded  and exited or taken public  innovative life science companies the venture capital firm has assets under management of 9 million for more information visit wwwrivervestcom media contact callaway zuccarello callawaycallawayandcocom read at biospacecom read at medcity news related news horizon discovery group plc and adarza biosystems inc enter supply  licensing agreement heres what to expect from the chan zuckerberg initiative adarza biosystems inc gets new life science seed funds first k investment  women leading biotech in europe biogenerator investment helps adarza biosystems inc establish operations in st louis how trumps tax cuts could propel novartis ag nvs to invest more in the us our new economy adarza biosystems inc changing future of diagnostic testing a look at whether johnson  johnson jnj passes warren buffets acquisition test why celgene celg could be considered risky because of donald trump theranos last defender claims federal witch hunt please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • medcity news • adarza biosystems inc   • biotechpharma  finance • diagnostics • medical dev  diag  finance                  home home    x special opportunity fund lpnicholas walrod   9email  infoxfundcom  x special opportunity fund lp all rights reserved microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext9 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft   pitchbook data inc all rights reserved get a detailed picture of a fund managers performance  connect fund returns to an individual partners track record gain insight into portfolio construction quarterly cashflows and specific deals driving returns dont miss out on top performing funds identify historically high performing firms with funds open now and in the near future filter results to find the opportunities that meet your mandate including size geography industry and more  what can pitchbook do for you  funds 9 lines of performance data manage risks in pe  vc investments know whats going on in the global pe and vc space track industry trends to assess risk and overconcentration to inform your investment strategy rise above todays obscure benchmarking standards build a custom peer group for your pe  vc investments and evaluate fund by fund performance with relevant metrics including irrs dpi rvpi tvpi and pme see the pitchbook platform in action request a free trial take the pitchbook platform for a spin request a free trial first name  last name  business email  company name optional request a free trial the pitchbook platform for limited partners   tackle your workflow  analytical challenges advanced screening search and filter down to the information thats most relevant to you data visualization custom charts and analysis tools illustrate emerging trends overconcentration allocation levels mature funds in the market and more mobile application access our global vc pe and ma data any time any place available for any ios or android device get all the information realtime portfolio monitoring transparency matters training and custom research follow lists and individual companies firms and people set alerts to stay on top of activity in your space view contact information and linkedin profiles of professionals companies and firms right in the platform feel confident in your analysis with access to quarter by quarter performance and cashflows for funds and lps maximize your access with unlimited personalized training and custom research support enhanced networking our full access model allows you to connect the dots between commitments partners deals and returns fix the following errorshide   pitchbook data inc all rights reserved what can pitchbook do for you  global private companies better private company research starts here request a free trial first name  last name  business email  company name optional request a free trial the pitchbook platform for private company data   tackle your workflow  analytical challenges advanced screening search and filter down to the information thats most relevant to you data visualization custom charts and analysis tools illustrate trends valuations levels deal activity top investors exits and more access our global vc pe and ma data any time any place available for any ios or android device custom activity alerts crm integration training and custom research mobile application excel plugin follow lists and individual companies firms and people set alerts to stay on top of activity in your space view contact information and linkedin profiles of professionals companies and firms right in the platform integrate our data into your crm software update existing accounts and populate new records  maximize your access with unlimited personalized training and custom research support enhanced networking access our data within excel using prebuilt templates or your own models update your analysis with a single click who and what you can research with pitchbook   companies ​pe  vc backed startup and angelbacked mature private companies public companies strategic acquirers investors ​portfolio lead partners deal details partners deals ​valuations  multiples cap tables particiapnts deal history exits  ipos ma ​strategic ma sponsored ma public and private ma secondary transactions limited partners ​mandates allocations commitments returns funds ​irrs dpi rvpi tvpi pme custom benchmarks financials ​key private company financials full public company fundamentals advisors ​industry expertise regional focus lead partners  teams clients  network people ​contact information linkedin connections board seats deal experience bio  education news  analysis ​news quarterly reports data visualization custom analytics ready for a better way to research private companies request a free trial discover whos backing a company view current and past investors track how much stake they have in the company explore company profiles access information about a companys background its team members deal history financials contact details and more track company growth and momentum get the full picture of a companys momentum by combining financing data with pb company signals  nonfinanical growth metrics like web traffic app downloads social media engagement and employee count explore financing history and valuations see a startups entire financing history related transaction details pre and postmoney valuations full cap tables and other relevant financial information fix the following errorshide   pitchbook data inc all rights reserved dive into transcaction details see a synopsis of the deal valuations ebitda and revenue multiples capital structure key terms and more see whos involved discover which investors led the deal who else participated and the advisors lawyers and lenders that helped make it happen what can pitchbook do for you 9 deals  companies know the deal landscape track every pe and vc transaction corporate investment or acquisition within any given industry or vertical run deal comparables easily analyze precedent private transactions for similar companies to better understand how a company is valued and deals are structured see the pitchbook platform for yourself request a free trial take the pitchbook platform for a spin request a free trial first name  last name  business email  company name optional request a free trial the pitchbook platform for deals data   tackle your workflow  analytical challenges advanced screening search and filter down to the information thats most relevant to you data visualization custom charts and analysis tools illustrate trends valuations levels deal activity top investors exits and more mobile application access our global ma pe and vc data any time any place avaliable for iphone android  windows phone excel plugin custom activity alerts crm integration training and custom research follow lists and individual companies firms and people set alerts to stay on top of activity in your space view contact information and linkedin profiles of professionals companies and firms right in the platform integrate our data into your crm software update existing accounts and populate new records  maximize your access with unlimited personalized training and custom research support enhanced networking access our data within excel using prebuilt templates or your own models update your analysis with a single click   fix the following errorshide what can pitchbook do for you your hunt for the next big thing starts here request a free trial first name  last name  business email  company name  phone number optional request a free trial   pitchbook data inc all rights reserved track global venture activity understand whats going on in the space where you play the deals taking place and whos involved scout out developing markets and growing sectors price your deals with confidence access the worlds largest source of pre and postmoney valuations cap tables and terms for vcbacked companies the pitchbook platform for venture capital   keep tabs on your peers monitor your peers every move with insight into their focus and portfolio construction where theyre sourcing deals and how theyre valuing them better pitch your fund and show how your firm is creating value  clearly communicate your funds performance relative to peers and support your strategys fit relative to others  tackle your workflow  analytical challenges advanced screening search and filter down to the information thats most relevant to you data visualization custom charts and analysis tools illustrate trends valuations levels deal activity top investors exits and more access our global vc pe and ma data any time any place available for any ios or android device custom activity alerts crm integration training and custom research mobile application excel plugin follow lists and individual companies firms and people set alerts to stay on top of activity in your space view contact information and linkedin profiles of professionals companies and firms right in the platform integrate our data into your crm software update existing accounts and populate new records  maximize your access with unlimited personalized training and custom research support enhanced networking access our data within excel using prebuilt templates or your own models update your analysis with a single click take the first step toward being a better vc investor request a free trial fix the following errorshide